137 related articles for article (PubMed ID: 9323593)
1. LDL receptor family-dependent and -independent pathways for the internalization and digestion of lipoprotein lipase-associated beta-VLDL by rat vascular smooth muscle cells.
Weaver AM; Lysiak JJ; Gonias SL
J Lipid Res; 1997 Sep; 38(9):1841-50. PubMed ID: 9323593
[TBL] [Abstract][Full Text] [Related]
2. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase.
Mulder M; Lombardi P; Jansen H; van Berkel TJ; Frants RR; Havekes LM
J Biol Chem; 1993 May; 268(13):9369-75. PubMed ID: 8387492
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein lipase binds to low density lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproteins in vitro.
Medh JD; Bowen SL; Fry GL; Ruben S; Andracki M; Inoue I; Lalouel JM; Strickland DK; Chappell DA
J Biol Chem; 1996 Jul; 271(29):17073-80. PubMed ID: 8663292
[TBL] [Abstract][Full Text] [Related]
4. Cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipase.
Chappell DA; Inoue I; Fry GL; Pladet MW; Bowen SL; Iverius PH; Lalouel JM; Strickland DK
J Biol Chem; 1994 Jul; 269(27):18001-6. PubMed ID: 7517936
[TBL] [Abstract][Full Text] [Related]
5. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes.
Argraves KM; Battey FD; MacCalman CD; McCrae KR; Gåfvels M; Kozarsky KF; Chappell DA; Strauss JF; Strickland DK
J Biol Chem; 1995 Nov; 270(44):26550-7. PubMed ID: 7592875
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate proteoglycans mediate internalization and degradation of beta-VLDL and promote cholesterol accumulation by pigeon macrophages.
Seo T; St Clair RW
J Lipid Res; 1997 Apr; 38(4):765-79. PubMed ID: 9144091
[TBL] [Abstract][Full Text] [Related]
7. Structure-function relationship of lipoprotein lipase-mediated enhancement of very low density lipoprotein binding and catabolism by the low density lipoprotein receptor. Functional importance of a properly folded surface loop covering the catalytic center.
Salinelli S; Lo JY; Mims MP; Zsigmond E; Smith LC; Chan L
J Biol Chem; 1996 Sep; 271(36):21906-13. PubMed ID: 8702993
[TBL] [Abstract][Full Text] [Related]
8. Heparan sulphate proteoglycans are involved in the lipoprotein lipase-mediated enhancement of the cellular binding of very low density and low density lipoproteins.
Mulder M; Lombardi P; Jansen H; van Berkel TJ; Frants RR; Havekes LM
Biochem Biophys Res Commun; 1992 Jun; 185(2):582-7. PubMed ID: 1610351
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans.
Williams KJ; Fless GM; Petrie KA; Snyder ML; Brocia RW; Swenson TL
J Biol Chem; 1992 Jul; 267(19):13284-92. PubMed ID: 1320015
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase.
Takahashi S; Suzuki J; Kohno M; Oida K; Tamai T; Miyabo S; Yamamoto T; Nakai T
J Biol Chem; 1995 Jun; 270(26):15747-54. PubMed ID: 7797576
[TBL] [Abstract][Full Text] [Related]
11. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
Murdoch SJ; Breckenridge WC
Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein lipase-mediated uptake of lipoprotein in human fibroblasts: evidence for an LDL receptor-independent internalization pathway.
Fernández-Borja M; Bellido D; Vilella E; Olivecrona G; Vilaró S
J Lipid Res; 1996 Mar; 37(3):464-81. PubMed ID: 8728311
[TBL] [Abstract][Full Text] [Related]
13. Can lipoprotein lipase be the culprit in cholesteryl ester accretion in smooth muscle cells in atheroma?
Stein O; Ben-Naim M; Dabach Y; Hollander G; Halperin G; Stein Y
Atherosclerosis; 1993 Feb; 99(1):15-22. PubMed ID: 8461056
[TBL] [Abstract][Full Text] [Related]
14. Transcytosis of lipoprotein lipase across cultured endothelial cells requires both heparan sulfate proteoglycans and the very low density lipoprotein receptor.
Obunike JC; Lutz EP; Li Z; Paka L; Katopodis T; Strickland DK; Kozarsky KF; Pillarisetti S; Goldberg IJ
J Biol Chem; 2001 Mar; 276(12):8934-41. PubMed ID: 11121409
[TBL] [Abstract][Full Text] [Related]
15. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.
Ji ZS; Brecht WJ; Miranda RD; Hussain MM; Innerarity TL; Mahley RW
J Biol Chem; 1993 May; 268(14):10160-7. PubMed ID: 7683668
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.
Medh JD; Fry GL; Bowen SL; Ruben S; Wong H; Chappell DA
J Lipid Res; 2000 Nov; 41(11):1858-71. PubMed ID: 11060356
[TBL] [Abstract][Full Text] [Related]
17. Very-low-density lipoprotein-induced triglyceride accumulation in human mesangial cells is mainly mediated by lipoprotein lipase.
Li J; Li H; Wen YB; Li XW
Nephron Physiol; 2008; 110(1):p1-10. PubMed ID: 18698144
[TBL] [Abstract][Full Text] [Related]
18. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans.
Huff MW; Miller DB; Wolfe BM; Connelly PW; Sawyez CG
J Lipid Res; 1997 Jul; 38(7):1318-33. PubMed ID: 9254059
[TBL] [Abstract][Full Text] [Related]
19. Segments in the C-terminal folding domain of lipoprotein lipase important for binding to the low density lipoprotein receptor-related protein and to heparan sulfate proteoglycans.
Nielsen MS; Brejning J; García R; Zhang H; Hayden MR; Vilaró S; Gliemann J
J Biol Chem; 1997 Feb; 272(9):5821-7. PubMed ID: 9038197
[TBL] [Abstract][Full Text] [Related]
20. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
Ji ZS; Fazio S; Mahley RW
J Biol Chem; 1994 May; 269(18):13421-8. PubMed ID: 8175773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
